share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  03/13 04:37
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares of the company on 03/12/2024, with an aggregate market value of $261,375.83. The shares were originally acquired on 04/20/2021 as pre-IPO shares from the issuer for the same amount and paid in cash. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold for gross proceeds of approximately $1.4 million.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares of the company on 03/12/2024, with an aggregate market value of $261,375.83. The shares were originally acquired on 04/20/2021 as pre-IPO shares from the issuer for the same amount and paid in cash. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold for gross proceeds of approximately $1.4 million.
Recursion Pharmicals, Inc.高管塞科拉·邁克爾定於2024年12月3日出售該公司的25,000股A類股票，總市值爲261,375.83美元。這些股票最初是在2021年4月20日作爲首次公開募股前的股票以相同金額從發行人手中收購的，並以現金支付。此次即將進行的出售是在過去三個月進行的一系列交易之後進行的，共出售了15萬股股票，總收益約爲140萬美元。
Recursion Pharmicals, Inc.高管塞科拉·邁克爾定於2024年12月3日出售該公司的25,000股A類股票，總市值爲261,375.83美元。這些股票最初是在2021年4月20日作爲首次公開募股前的股票以相同金額從發行人手中收購的，並以現金支付。此次即將進行的出售是在過去三個月進行的一系列交易之後進行的，共出售了15萬股股票，總收益約爲140萬美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。